First-Of-Its-Kind Autism Software Could Help Diagnose, Treat Children Faster: FDA
The US agency says a lack of specialists often lead to delays in diagnosing children and prevents them from getting much-needed help during a treatment time frame, which the new breakthrough device can help fix.
You may also be interested in...
FDA clearance of the ASD Diagnostic app could lead to early diagnosis, improving quality of life of children with ASD and their caregivers.
US regulators say Verily’s Study Watch – meant to be used in Parkinson’s trials – doesn’t collect data needed to assess whether a patient is truly benefitting from a drug.
The US regulator’s report is meant to help develop new federal cybersecurity purchasing guidelines that could eventually be used to implement a cybersecurity consumer labeling program.